Gracell Biotechnologies Inc.: cash_and_restricted_cash

Value	`{"amount": 273063000, "concept": "us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "currency": "USD"}`
Period	(as of 2021-12-31)
Status	superseded
Entity	Gracell Biotechnologies Inc.

Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference: 0001193125-22-221202
Retrieved: 2026-08-19T18:23:15.844735+02:00
Raw response sha256: f7bde1a401b286c74a2fd824ee1df541…
Cite as: FACTANKER, https://factanker.com/fact/a94ceb46-40f9-49d8-a152-ed2148b2f554

History

supersedes {"amount": 287011000, "concept": "us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "currency": "USD"} (evidence 0001193125-22-115083)